BRCA2 and breast carcinoma: A previous study in Qatar evaluated the impact of BRCA1 and BRCA2 pathogenic mutations on breast cancer aggressiveness in carriers versus non-carriers, involving 82 women diagnosed with breast cancer at the age of 50 or younger [25].